ストックスクリーナーアプリを入手
2.47
1.59%
-0.04
前日終値:
$2.51
開ける：
$2.56
24時間の取引高:
586.32K
Relative Volume:
0.68
時価総額：
$204.64M
収益：
$70.14M
当期純損益:
$-76.24M
株価収益率:
-2.2252
EPS:
-1.11
ネットキャッシュフロー:
$-57.06M
1週間 パフォーマンス:
+0.41%
1か月 パフォーマンス:
+16.51%
6か月 パフォーマンス:
-36.34%
1年 パフォーマンス:
-34.48%
1日の値動き範囲:
$2.378
$2.575
1週間の範囲:
$1.95
$2.70
52週間の値動き範囲:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
CDXS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.47 | 203.80M | 70.14M | -76.24M | -57.06M | -1.11 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-19 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-05-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-29 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-11-07 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-08-07 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | 再開されました | Piper Sandler | Overweight |
| 2022-03-02 | 再開されました | Cowen | Outperform |
| 2021-04-12 | 開始されました | Piper Sandler | Overweight |
| 2021-03-01 | 開始されました | Stifel | Buy |
| 2021-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-10 | 開始されました | The Benchmark Company | Buy |
| 2019-01-17 | アップグレード | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | 開始されました | Stephens | Overweight |
| 2017-10-13 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-31 | 開始されました | Jefferies | Buy |
| 2017-01-26 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Codexis Inc (CDXS) 最新ニュース
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Codexis, Inc. (NASDAQ:CDXS) Q1 2025 Earnings Call Transcript - Insider Monkey
Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Stifel Financial Corp - Defense World
Codexis reiterates $64M-$68M 2025 revenue guidance as ecosynthesis platform gains traction with CDMOs - MSN
Stifel maintains Buy rating on Codexis stock with $5 target By Investing.com - Investing.com India
Stifel maintains Buy rating on Codexis stock with $5 target - Investing.com Australia
Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with Strategic Growth Initiatives - GuruFocus
Codexis Inc (CDXS) Q1 2025 Earnings: EPS at -$0.23 and Revenue H - GuruFocus
Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with ... - Yahoo Finance
Codexis Reports Q1 2025 Financial Results and Strategic Progress - TipRanks
Codexis: Q1 Earnings Snapshot - MySA
Earnings call transcript: Codexis Q1 2025 results miss forecasts, stock declines - Investing.com Nigeria
Codexis (CDXS) Navigates Q1 Revenue Challenges, Confirms 2025 Ou - GuruFocus
Codexis, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:CDXS) - Seeking Alpha
Codexis (CDXS) Projects Financial Stability Until 2026 | CDXS St - GuruFocus
Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Codexis (CDXS) Reports Lower Than Expected Q1 Revenue, Affirms 2 - GuruFocus
Codexis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Codexis May 2025 presentation slides: RNA manufacturing pivot targets path to profitability - Investing.com Australia
CODEXIS Earnings Results: $CDXS Reports Quarterly Earnings - Nasdaq
Codexis (CDXS) Reports Lower Than Expected Q1 Revenue, Affirms 2025 Outlook | CDXS Stock News - GuruFocus
Codexis Reports First Quarter 2025 Financial Results - TradingView
Codexis Secures Landmark ECO Synthesis Deal as Q1 Earnings Show Strategic Pivot to RNA Manufacturing - Stock Titan
Thinking Of Selling Codexis Inc (NASDAQ: CDXS) Stock? Check This Out First - Stocksregister
MetLife Investment Management LLC Increases Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis, Inc. (NASDAQ:CDXS) Shares Bought by Wells Fargo & Company MN - Defense World
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Codexis, Inc. (NASDAQ: CDXS) and Encourages CDXS Shareholders to Contact the Firm - ACCESS Newswire
Financial Metrics Exploration: Understanding Codexis Inc (CDXS) Through Ratios - DWinneX
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting - GlobeNewswire
Codexis, Inc. (NASDAQ:CDXS) Stake Increased by Barclays PLC - Defense World
Recent uptick might appease Codexis, Inc. (NASDAQ:CDXS) institutional owners after losing 36% over the past year - simplywall.st
Top 5 Synthetic Biology Public Companies (May 2025) - Securities.io
BlackRock, Inc. Reduces Stake in Codexis Inc. - GuruFocus
Codexis to Report First Quarter 2025 Financial Results on May 14 - The Manila Times
Codexis, Inc. to Release First Quarter 2025 Financial Results on May 14, 2025 - Nasdaq
Codexis Q1 2025 Earnings Call: Key Details for Investors RevealedMark Your Calendar - Stock Titan
Opaleye Management Makes Strategic Move with Codexis Stock Purchase - TipRanks
Codexis, Inc. (NASDAQ:CDXS) Shares Bought by JPMorgan Chase & Co. - Defense World
Envestnet Asset Management Inc. Purchases 110,541 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Codexis Inc (CDXS) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocksregister
Codexis, Inc. (NASDAQ:CDXS) Holdings Decreased by Russell Investments Group Ltd. - Defense World
Codexis Inc [CDXS] Shares Rise 2.24 % on Wednesday - knoxdaily.com
Codexis Inc (CDXS) stock analysis: A comprehensive overview - uspostnews.com
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Geode Capital Management LLC Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis (CDXS) to Release Quarterly Earnings on Thursday - The AM Reporter
Codexis (CDXS) Projected to Post Earnings on Thursday - Defense World
Quarterly Snapshot: Quick and Current Ratios for Codexis Inc (CDXS) - DWinneX
Global Biocatalysis Market Growth Trends & Insights2024-2031 - openPR.com
Codexis Inc (CDXS) 財務データ
収益
当期純利益
現金流量
EPS
Codexis Inc (CDXS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
May 01 '25 |
Buy |
2.32 |
20,000 |
46,436 |
9,675,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 25 '25 |
Buy |
2.24 |
25,000 |
55,915 |
9,630,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 16 '25 |
Buy |
2.13 |
70,000 |
148,890 |
9,560,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 17 '25 |
Buy |
2.09 |
45,000 |
94,162 |
9,605,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 15 '25 |
Buy |
2.23 |
25,000 |
55,720 |
9,490,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 08 '25 |
Buy |
1.98 |
100,000 |
198,380 |
9,465,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 03 '25 |
Buy |
2.30 |
75,000 |
172,740 |
9,365,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 01 '25 |
Buy |
2.48 |
35,000 |
86,772 |
9,285,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 02 '25 |
Buy |
2.46 |
5,000 |
12,276 |
9,290,000 |
| Opaleye Management Inc. | 10% Owner |
Mar 21 '25 |
Buy |
2.54 |
92,923 |
236,266 |
9,250,000 |
1.54%
7.58%
大文字化:
|
ボリューム (24 時間):